Novartis: Clinical trials

- novartisclinicaltrials.com
514,946 $ 2,400.00


GLEEVEC® (imatinib mesylate) | KIT + GIST & Ph+ CML

- gleevec.com

Learn about GLEEVEC, an approved treatment for KIT+ GIST and Philadelphia chromosome-positive chronic myeloid leukemia. See full Prescribing & Safety Info.

4,150,500 $ 240.00